🏥 Health
1d ago
Nonobstructive Heart Enlargement Responds to Aficamten
Source ↗
👁 0
💬 0
(MedPage Today) -- Treatment with aficamten (Myqorzo) improved exercise capacity as well as health status and symptoms in patients with symptomatic nonobstructive hypertrophic cardiomyopathy (HCM) in a large, double-blind, placebo-controlled trial...
Comments (0)